Schlevogt, B.; Kinast, V.; Reusch, J.; Kerkhoff, A.; Praditya, D.; Todt, D.; Schmidt, H.H.; Steinmann, E.; Behrendt, P.
Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib Treatment. Pathogens 2019, 8, 129.
https://doi.org/10.3390/pathogens8030129
AMA Style
Schlevogt B, Kinast V, Reusch J, Kerkhoff A, Praditya D, Todt D, Schmidt HH, Steinmann E, Behrendt P.
Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib Treatment. Pathogens. 2019; 8(3):129.
https://doi.org/10.3390/pathogens8030129
Chicago/Turabian Style
Schlevogt, Bernhard, Volker Kinast, Julia Reusch, Andrea Kerkhoff, Dimas Praditya, Daniel Todt, Hartmut H. Schmidt, Eike Steinmann, and Patrick Behrendt.
2019. "Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib Treatment" Pathogens 8, no. 3: 129.
https://doi.org/10.3390/pathogens8030129
APA Style
Schlevogt, B., Kinast, V., Reusch, J., Kerkhoff, A., Praditya, D., Todt, D., Schmidt, H. H., Steinmann, E., & Behrendt, P.
(2019). Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib Treatment. Pathogens, 8(3), 129.
https://doi.org/10.3390/pathogens8030129